22141-Rectal Cancer-NA-56

Rectal Cancer

A Phase 1 Study of RGX-202-01, a Small Molecule Inhibitor of the Creatine Transporter, SLC6a8, as a Single Agent and as Combination Therapy in Patients with Advanced Gastrointestinal Malignancies with Select Expansion Cohorts (RGX-202-001)

  • Details

ClinicalTrials.gov ID: NCT03597581
Diagnosis Type: NA
USOR Number:

  • Address

4715 Arapahoe Avenue
Boulder, CO 80303
P: (303) 385-2000

Search by practice name, trial titles, indicators and specific disease types.